A detailed history of Wolverine Trading, LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 29,839 shares of SENS stock, worth $15,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,839
Previous 73,800 59.57%
Holding current value
$15,516
Previous $29,000 65.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $0.49 $9,548 - $14,621
29,839 New
29,839 $10,000
Q3 2023

Nov 15, 2023

BUY
$0.5 - $1.05 $10,644 - $22,352
21,288 New
21,288 $12,000
Q1 2023

May 15, 2023

SELL
$0.68 - $1.25 $18,098 - $33,270
-26,616 Reduced 67.49%
12,822 $9,000
Q4 2022

Feb 14, 2023

SELL
$0.96 - $1.34 $1,258 - $1,756
-1,311 Reduced 3.22%
39,438 $41,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $19,921 - $43,554
19,531 Added 92.05%
40,749 $58,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $80,505 - $166,149
-85,644 Reduced 80.14%
21,218 $21,000
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $72,281 - $174,132
-46,936 Reduced 30.52%
106,862 $204,000
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $190,311 - $288,417
-73,764 Reduced 32.41%
153,798 $423,000
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $295,060 - $431,406
106,520 Added 88.0%
227,562 $744,000
Q2 2021

Aug 06, 2021

SELL
$1.71 - $4.14 $151,594 - $367,019
-88,652 Reduced 42.28%
121,042 $478,000
Q1 2021

May 14, 2021

BUY
$0.85 - $5.27 $161,835 - $1 Million
190,395 Added 986.55%
209,694 $568,000
Q4 2020

Feb 12, 2021

BUY
$0.36 - $0.95 $1,425 - $3,761
3,959 Added 25.81%
19,299 $17,000
Q1 2019

May 15, 2019

BUY
$2.3 - $3.27 $35,282 - $50,161
15,340 New
15,340 $38,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $242M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.